What’s New? April 2021

SOPHiA GENETICS is excited to celebrate Clinical Trials Day. This blog dives a little deeper into the history of

Every person is unique. We can clearly see this within the more than one million genomic profiles from 70

Third party sequencing services can enable increased access to NGS testing, but if institutions do not receive access to

SOPHiA GENETICS has reached a major milestone on a global scale by analyzing one million genomic profiles.

The field of precision medicine continues to evolve but remains steadfast in its goal to provide the right treatment

Larger panels may cast wider nets, but optimization with patented algorithms through our universal platform gives more actionable insights

Increased access to genomic testing can help fulfill the promise of making precision medicine accessible to all, but the

By leveraging expertly curated evidence, powered by JAX-CKB, and SOPHiA GENETICS’ patented algorithms through the SOPHiA DDM platform, users

The President acknowledged that the US still has much further to come in advancing data-driven initiatives and that many

2021 has been a big year for SOPHiA GENETICS. Here's a recap of some of the major highlights...

Radiomics maximizes upon information that’s already being collected. The difference is how that info is used.

About half of all breast cancer patients develop the disease outside of the period of ages 50-69 and could